Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Pathfinder Cell Therapy Inc. (PFND) had Consolidated Net Income/Loss of $-9.07M for the most recently reported fiscal quarter, ending 2011-09-30.
| Income Statement Financials | |
$0.01M |
|
$-9.07M |
|
-- |
|
$0.01M |
|
-- |
|
$0.01M |
|
-- |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
$-9.07M |
|
|
Consolidated Net Income/Loss |
$-9.07M |
$0.01M |
|
$0.01M |
|
$0.01M |
|
522.36M |
|
522.36M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
-- |
|
100.00% |
|
-181400.00% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|